|
× |
 |
A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment PDF |
$40.00 |
|
$40.00 |
|
× |
|
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Implication of Combat Stress and PTSD Trajectories in Metabolic Syndrome and Elevated C-Reactive Protein Levels: A Longitudinal Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Effect of Psychotic Symptoms on Decision-Making Capacity and Its Assessment in a Patient With Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Postprandial Oxytocin Secretion Is Associated With Severity of Anxiety and Depressive Symptoms in Anorexia Nervosa PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prevention of Dopamine Dysregulation Syndrome in Parkinson's Disease: A Case Report PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Prospective Study of Parentally Bereaved Youth, Caregiver Depression, and Body Mass Index PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism. PDF |
$40.00 |
|
$40.00 |
|
|
